Global Injectable Nanomedicines Market Expected to Reach USD 833.9 Million by 2025 by nikitamanwar · October 10 Casemiro Brazil Jersey , 2019
The global聽injectable nanomedicines market聽touched USD 479.6 million in 2017, and is expected to reach USD 833.9 million by 2025, growing at a CAGR of 7.3% during 2018鈥?025.
Source: GMI Research
Major Factors driving the market growth are: 路 Growing incidence of chronic diseases like cancer, cardiovascular diseases, neurological disorders 路 Increasing research & development activities and clinical trials 路 Rising demand and adoption of minimally invasive treatments 路 Rising government and private funding 路 Increasing geriatric population
Growing demand for minimal invasive treatments is driving the Injectable Nanomedicines market. Introduction of innovative and advanced nanotechnology and nanomedicines Alisson Brazil Jersey , especially in the emerging markets with the help of government and private funding would spur the growth of market for the injectable nanomedicines during the forecast period.
Request for Sample Report 鈥? A paradigm shifts from traditional therapeutics to novel therapeutics using nanomedicines is propelling the overall market as nanomedicines have higher payload capacity, prolonged blood circulation times, reduced toxicity and improved anti-tumour efficacy. Moreover, the application of injectable nanomedicines for some widespread chronic diseases like migraine and depression is also aiding market growth. The use of injectable nanomedicines are found to be efficient, lasting and easy treatment of many chronic cardiovascular and neurological disorders.
Growing incidence rate due to aging demographic patterns and the extension of health insurance coverage in a developing region will support the market growth. Advancements in cancer drug delivery and personalized cancer treatments Alex Sandro Brazil Jersey , effective and safe treatment of medically refractory movement disorders and the need for fast and efficient cardiovascular systems will primarily drive the global injectable nanomedicine market.
鈥淭he rising pool of patients of chronic diseases and the need for a fast, efficient and long-lasting treatment with minimal invasion procedures will drive the injectable nanomedicines market.鈥?br > 鈥?GMI Research
Based on geography, North America held the largest market share in 2017 due to the significantly high rate of incidence of cancer as well as cardiovascular diseases in the region. Currently, the region has a growing demand for rapid research & development of novel nanomedicine in order to address unmet medical needs. Furthermore, favourable reimbursement policies and increasingly growing partnerships between leading enterprises and nanomedicine start-ups is also expected to create growth opportunities. Europe is the second largest market in 2017 and is promising market due to developed healthcare system and rising adoption of nanomedicine in oncology sector. Asia-Pacific is expected to show promising growth in global injectable nanomedicines during 2018-2025 due to the increasing government and private funding for health care infrastructure along with the rising incidence of neurological disorders. Moreover Wholesale Brazil Soccer Jerseys , increasing adoption of nanomedicine for the treatment of cancer, diabetes, cardiovascular diseases and some infectious disease in the Asia-Pacific region would also contribute significantly to the market growth for injectable nanomedicines in the region.
Based on geography, North America held the largest market share in 2017 due to the significantly high rate of incidence of cancer as well as cardiovascular diseases in the region. Currently, the region has a growing demand for rapid research & development of novel nanomedicine in order to address unmet medical needs. Furthermore Wholesale Brazil Jerseys , favourable reimbursement policies and increasingly growing partnerships between leading enterprises and nanomedicine start-ups is also expected to create growth opportunities. Europe is the second largest market in 2017 and is promising market due to developed healthcare system and rising adoption of nanomedicine in oncology sector. Asia-Pacific is expected to show promising growth in global injectable nanomedicines during 2018-2025 due to the increasing government and private funding for health care infrastructure along with the rising incidence of neurological disorders. Moreover, increasing adoption of nanomedicine for the treatment of cancer, diabetes, cardiovascular diseases and some infectious disease in the Asia-Pacific region would also contribute significantly to the market growth for injectable nanomedicines in the region.
Key takeawayskey essentials: 路 In 2017, the cancer treatment held the major share for the injectable nanomedicines market followed by the cardiovascular diseases segment. 路 High demand and adoption rate for minimally invasive treatments in the recent past. 路 Extended research and development activities are taking place using the injectable nanomedicines regarding the concept of targeted drug delivery system.
Some of the key players operating in the global market for injectable nanomedicines include Merck & Co. Cheap Brazil Soccer Jerseys , Inc., Lupin, Pacira Pharmaceuticals Inc., Celgene Pharmaceutical Co. Ltd., Amgen Cheap Brazil Jerseys , Inc., Janssen Biotech Inc., Pfizer Inc., Hoffmann-La Roche Ltd., Teva Pharmaceutical Industries Ltd. Willian Brazil Jersey , Bausch & Lomb Inc. among others.
The聽global聽injectable nanomedicines market聽has been segmented based on product type, indication type and key geographies. Based on the product type, global injectable nanomedicines market has been segmented into liposomes, micelles, nanocrystals and others. Based on indication type Weverton Brazil Jersey , t
Wirtschaft aus aller Welt
Thema drucken
18.03.2020 09:00
Antworten
